Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.11 USD
Change Today +0.05 / 2.43%
Volume 286.3K
ATNM On Other Exchanges
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Geraldine A. Henwood Ph.D.

Chief Development Officer of Iomab-B,Actinium Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 4 different organizations across 8 different industries.

See Board Relationships


Dr. Geraldine A. Henwood, also known as Gerri, Ph.D., has been the Chief Development Officer of Iomab-B at Actinium Pharmaceuticals, Inc. since September 2012. Dr. Henwood has been the Chief Executive Officer of Garnet Biotherapeutics, Inc. since November 2008. She has been the Chief Executive Officer and President of RECRO Pharma, Inc. since 2008. She is a Venture Partner at SCP Vitalife. She is the Founder of Malvern Consulting Group and served as its President from ...

Read Full Background

Corporate Headquarters*

546 Fifth Avenue
New York, New York 10036

United States

Phone: 646-459-4201
Fax: --

Board Members Memberships*

Chief Executive Officer and Director
Chief Executive Officer, President and Director
Director and Member of Compensation Committee


Neumann University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$490,375

Stock Options*

All Other Compensation$23,645
Exercisable Options17,914
Unexercisable Options205,586
Total Number of Options347,000

Total Compensation*

Total Annual Cash Compensation$514,020
Total Short Term Compensation$490,375
Other Long Term Compensation$23,645
Total Calculated Compensation$1,507,860
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATNM:US $2.11 USD +0.05


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTINIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at